Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are d
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/5b7bde99ebf4bcf365c67209fb6357f7.jpg"/><p>Several weight loss drug stocks are [...]
Hims & Hers stock jumps 14% after FDA schedules peptide compounding rev
The FDA will convene an outside panel in July to weigh compounding eligibility for 7 peptides, a category Hims & Hers has been positioning to enter
[...]
Hims & Hers Expands Personalized Digital Healthcare Platform
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.
[...]